Chronic Headache Education and Self-management Study (CHESS) is a multi-centre, randomised controlled trial evaluating an education and self-management support programme for people living with chronic headaches (headache ≥ 15 days/month for ≥ 3 months).
This interactive day is a must for students, GPs, registrars, researchers, and allied health professionals. The event aims to inspire, translate and innovate primary care research by showing current research.
Pauline Boyle Chief Operating Officer, Clinical Research Network West Midlands: Supporting the Delivery of Research in the Primary Care Setting
Over one million people have taken part in Primary Care research nationally in the past 10 years, and 175,000 of these were recruited in GP practices in the West Midlands. The contribution of these practices is significantly helping the NHS to gather evidence about new treatments and services in order to improve patient care
The Clinical Research Network West Midlands Primary Care PPIE team are supporting the roll out of the NIHR Patient Research Ambassador Initiative.
Patient Research Ambassadors (PRA) promote health research from a patient point of view. They could be a patient, service user, carer or lay person who is enthusiastic about health research and willing to communicate that to other patients and public as well as healthcare professionals
The Diagnostic and Prognostic Value of the Symptom of Shortness of Breath in Primary Care: A Cohort Study
Complaints of breathlessness and wheeze are common reasons why patients consult their GP, and may simply be a short-term and minor problem, or could be an early sign of chronic obstructive pulmonary disease (COPD), asthma, or ischaemic heart disease (IHD). The similarity of symptoms related to these conditions may make their diagnosis at initial presentation difficult, and often requires a number of tests.
Children with underlying medical conditions such as asthma, diabetes and cerebral palsy are ‘at risk’ of becoming more unwell from bacterial infections if they get flu. ARCHIE is a double-blind randomised placebo-controlled trial which aims to determine the effect of giving the antibiotic co-amoxiclav to ‘at risk’ children within five days of them becoming ill with flu or influenza-like illness.